@Brandon_Beaber Sure, largely psychological if you ignore local effects of such high doses on stomach mucosa as well as the relatively higher dose exposure to the gut associated lymphoid tissue.
These local effects are unknown at such high exposures and enough of a concern to avoid oral dosing
@Brandon_Beaber Also likely reflects poor terminology. Like Eskimo’s have multiple words for snow we likely need more words for subjective, clinical and objective activity in MS.
@Brandon_Beaber “Although RAM rate decreased with DMTs according to their expected efficacy, ACES rate was stable across DMTs.”
Given no impact of DMTs, it seems more likely that these events are unrelated to underlying inflammatory events and thus perhaps miscategorized as acute relapse.
@GavinGiovannoni I think MS is two problems. One is inflammatory in nature, and certainly may have an infectious link. The second is non-inflammatory in nature.
2020/21 were bad years and progress toward a cure suffered both setbacks and advancement.
I am confident breakthrough therapy for MS will be available in 5-10 years which will safely put the brakes on this disease; but we are in a holding pattern for the next 3 years. 🤞🙏🏻
@GavinGiovannoni The simple fact that we see progression of disease with AHSCT argues against it being a cure.
A highly effective treatment yes, but not a cure.
BUT, certainly using AHSCT first line should be studied given its effectiveness.
Wow....what a 2020. Gonna start off 2021 with a poll. Pls retweet so it gets more exposure. 🙏🏻 #MultipleSclerosis
For #MSers who have gotten Ocrevus/Keysimpta/Rituxan, did your heat intolerance go away?
Dear @wearfigs it’s me - a woman doctor
Holding Kaplan’s Cardiac Anesthesia RIGHT SIDE UP
The gold standard book for my subspecialty
Reading Chapter 15 Advanced Echocardiography Concepts (130 pages)
Of which I am the senior author.
Support women physicians. @AMWADoctors